Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1] Company Overview: Pacasmayo (CPAC) - Pacasmayo currently holds a Momentum Style Score of B, indicating a favorable momentum characteristic [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Performance Metrics - Over the past week, CPAC shares have increased by 52.07%, while the Zacks Building Products - Concrete and Aggregates industry remained flat [5] - In a longer timeframe, CPAC's monthly price change is 60.03%, significantly outperforming the industry's 0.57% [5] - Over the last three months, CPAC shares have risen by 46.67%, and over the past year, they have increased by 89.78%, compared to the S&P 500's gains of 4.03% and 16.96%, respectively [6] Trading Volume - CPAC's average 20-day trading volume is 202,935 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, one earnings estimate for CPAC has increased, while none have decreased, raising the consensus estimate from $0.69 to $0.79 [9] - For the next fiscal year, one estimate has moved upwards with no downward revisions during the same period [9] Conclusion - Given the strong performance metrics and positive earnings outlook, CPAC is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a compelling option for investors seeking short-term gains [11]

Company Overview - Cementos Pacasmayo (NYSE:CPAC) is a leading cement company in Peru, focusing on the production and distribution of cement, concrete, and other construction materials, primarily in the northern region of Peru [1] Market Performance - The current market price of CPAC is $10.48, reflecting a modest increase of 1.95% or $0.20, with a trading range today between $10.23 and $10.69, indicating some volatility [3] - Over the past year, CPAC has experienced a high of $11.30 and a low of $5.10, showcasing its potential for growth [3] - The company's market capitalization is approximately $897.5 million, with a trading volume of 49,293 shares [3] Investment Outlook - Scotiabank has set a price target of $12.80 for CPAC, suggesting a potential increase of approximately 22.14% from its current price [2][5] - Zacks Investment Research identifies CPAC as a potential interest for value investors, supported by its strong performance in the "Value" category of Zacks' Style Scores system [2][4][5]

Core Viewpoint - Cementos Pacasmayo (CPAC) is a leading cement company in Peru, recognized for its production and distribution of cement and construction materials, with a significant role in the construction industry [1] Group 1: Stock Performance - Scotiabank maintained a "Sector Perform" rating for CPAC, suggesting investors hold their positions, with the stock priced at $10.42 at that time [1] - CPAC's current stock price is approximately $10.46, reflecting a slight increase of 1.80% or $0.18, with trading between $10.15 and $10.69 today [3] - The stock has a 52-week high of $11.30 and a low of $5.10, indicating stable performance consistent with Scotiabank's recommendation [3] Group 2: Market Outlook - Scotiabank raised its price target for CPAC from $6.40 to $12.80, indicating a positive outlook and confidence in the company's growth potential [2] - Zacks Investment Research is evaluating CPAC, focusing on earnings estimates and revisions, considering it a strong candidate for value investing [2] Group 3: Company Metrics - CPAC's market capitalization is around $896.17 million, highlighting its size and influence in the market [4] - The company has a trading volume of 33,674 shares on the NYSE, indicating active trading and investor interest [4] - CPAC's performance in the "Value" category, along with a high Zacks Rank, positions it as a potentially strong value stock [4]

Company Overview - Cementos Pacasmayo (CPAC) is currently rated with a Zacks Rank of 2 (Buy) and has a Value grade of A, indicating strong potential for value investors [4] - The stock has a P/E ratio of 10.03, significantly lower than the industry average P/E of 23.97, suggesting it may be undervalued [4] - Over the past 52 weeks, CPAC's Forward P/E has fluctuated between a high of 13.10 and a low of 7.26, with a median of 8.91, further indicating its valuation dynamics [4] Valuation Metrics - The P/S ratio for CPAC stands at 1.58, compared to the industry average P/S of 3.38, reinforcing the notion that the stock is undervalued [5] - The P/S ratio is favored by value investors as it is less susceptible to manipulation compared to earnings figures, making it a reliable performance indicator [5] Investment Outlook - The combination of CPAC's strong earnings outlook and its favorable valuation metrics positions it as an impressive value stock at the moment [6]

Market Overview - U.S. stocks traded mostly lower, with the Dow Jones index falling more than 250 points, down 0.52% to 48,164.83, NASDAQ down 0.37% to 22,971.25, and S&P 500 down 0.56% to 6,778.08 [1] - European shares were lower, with the eurozone's STOXX 600 slipping 0.64%, Spain's IBEX 35 Index down 0.69%, London's FTSE 100 down 0.92%, Germany's DAX 40 down 0.85%, and France's CAC 40 declining 0.40% [5] - Asian markets closed lower, with Japan's Nikkei down 1.56%, Hong Kong's Hang Seng down 1.54%, China's Shanghai Composite down 1.11%, and India's BSE Sensex down 0.63% [6] Economic Indicators - U.S. retail sales were flat for October compared to September, down from a revised 0.1% gain in the previous month and below market estimates of 0.1% growth [7] - The U.S. economy added 64,000 jobs in November, compared to a loss of 105,000 in the previous month and above market estimates of a 50,000 increase [9] - The U.S. unemployment rate rose to 4.6% in November from 4.3% in the previous month, marking the highest reading since September 2021 [9] - Average hourly earnings for private nonfarm payrolls rose by 0.1% month-over-month to $36.86 in November, compared to a 0.4% rise in the previous month [9] - U.S. business inventories increased 0.2% month-over-month in September, in line with market estimates [9] - The S&P Global flash composite PMI declined to 53 in December, the lowest reading in six months, down from 54.2 in November [2][9] Commodity Market - Oil traded down 2.9% to $55.17, while gold traded up 0.5% at $4,357.00, silver up 0.1% to $63.59, and copper down 1% to $5.3560 [4] Company News - SRx Health Solutions Inc shares surged 92% to $0.59 after announcing an agreement to acquire EMJ Crypto Technologies [8] - Rezolve AI PLC shares rose 34% to $3.12 following preliminary December revenue results [8] - Cementos Pacasmayo SAA shares increased 48% to $10.25 after Holcim signed an agreement to purchase 50.01% of the company's owner [8] - Zynex Inc shares dropped 53% to $0.31 after entering Chapter 11 court-supervised financial restructuring [8] - Lightwave Logic Inc shares fell 19% to $3.05 after announcing the pricing of an 11.67M share common stock offering [8] - Navan Inc shares decreased 17% to $12.21 after reporting third-quarter results [8]

Group 1 - U.S. stocks experienced a decline, with the Dow Jones index dropping over 100 points on Tuesday [1] - Cementos Pacasmayo SAA – ADR shares surged 47.4% to $10.30 following Holcim's agreement to acquire 50.01% of its owner, Inversiones Aspi. S.A. [1] Group 2 - Rezolve AI PLC reported preliminary December revenue results, leading to a 23.7% increase in its stock price to $2.87 [2] - Emerald Holding Inc announced a review of potential strategic options, resulting in a 17% rise in its stock price to $4.14 [2] - NovaBay Pharmaceuticals Inc's stock increased by 16.2% to $3.15 [2] - Tilray Brands Inc saw a 15% surge in its stock price to $12.57 [2] - Clearpoint Neuro Inc's stock jumped 14.2% to $14.14 [2] - Fermi Inc gained 11.4%, reaching $9.57 [2] - Sezzle Inc authorized a $100 million stock buyback, leading to a 9.6% increase in its stock price to $72.49 [2] - WW International Inc launched a new platform for the GLP-1 era, resulting in a 7.8% gain to $26.19 [2] - Circle Internet Group Inc rose 7.7% to $81.24 [2] - Lemonade Inc's stock surged 7.4% to $80.59 [2] - Netskope Inc gained 6.9%, reaching $20.37 [2] - Ascentage Pharma Group International's stock rose 6% to $29.26 [2] - RH's stock increased by 5.5% to $172.60, with Barclays analyst maintaining an Overweight rating and lowering the price target from $385 to $283 [2] - Affirm Holdings Inc gained 4.4%, reaching $68.56 [2]

Group 1 - Holcim will acquire a majority stake in the target company [1] - The deal values the target company at $1.5 billion [1]

Company Overview - Pacasmayo (CPAC) is currently ranked 14 in the Zacks Sector Rank among 92 companies in the Construction group [2] - The company has a Zacks Rank of 2 (Buy), indicating a positive outlook based on earnings estimates and revisions [3] Performance Metrics - Year-to-date, Pacasmayo has returned 22%, significantly outperforming the Construction sector's average return of 3.5% [4] - The consensus estimate for Pacasmayo's full-year earnings has increased by 14.5% over the past 90 days, reflecting improved analyst sentiment [3] Industry Context - Pacasmayo operates within the Building Products - Concrete and Aggregates industry, which ranks 96 in the Zacks Industry Rank and has an average year-to-date gain of 18.6% [5] - In comparison, another stock in the Construction sector, Orion Energy Systems, Inc. (OESX), has returned 76.4% year-to-date and has a Zacks Rank of 2 (Buy) [4][5]

Core Viewpoint - Pacasmayo (CPAC) has experienced a significant downtrend, with a 13.1% decline over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from analysts [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 indicating that a stock may be oversold [2]. - CPAC's current RSI reading is 27.11, indicating that the heavy selling pressure may be exhausting, and a price reversal could occur soon [5]. Group 2: Fundamental Indicators - Analysts have raised their earnings estimates for CPAC by 14.5% over the last 30 days, which typically correlates with price appreciation in the near term [7]. - CPAC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [8].

Core Viewpoint - Pacasmayo (CPAC) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which are a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Movement - The Zacks rating system is effective for individual investors as it reflects changes in earnings estimates, which are strongly correlated with near-term stock price movements [2][3]. - Institutional investors often rely on earnings estimates to determine a company's fair value, leading to significant stock price movements based on their buying or selling activities [3]. Business Improvement Indicators - The upgrade in Pacasmayo's rating suggests an improvement in the company's underlying business, which should encourage investors to drive the stock price higher [4]. - Over the past three months, the Zacks Consensus Estimate for Pacasmayo has increased by 14.5%, indicating a positive trend in earnings estimates [7]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [6]. - The system maintains a balanced distribution of "buy" and "sell" ratings, ensuring that only the top 20% of stocks receive a "Strong Buy" or "Buy" rating, highlighting their superior earnings estimate revisions [8][9].